The Impact of the Target Therapy on Health Care Expenditure and Survival of Lung Adenocarcinoma Patients

The Impact of the Target Therapy on Health Care Expenditure and Survival of Lung Adenocarcinoma Patients

碩士 === 逢甲大學 === 財稅學系 === 101

Bibliographic Details
Main Author:	廖英如
Other Authors:	游慧光
Format:	Others
Language:	zh-TW
Published:	2013
Online Access:	http://ndltd.ncl.edu.tw/handle/90377676884580961994

Similar Items

Efficacy of First Line Target Therapy in Patients with Advanced Lung Adenocarcinoma
by: Yn-Fang Lin, et al.
Published: (2017)

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
by: Seok-Young Kim, et al.
Published: (2019-12-01)

Predicting medical expenditure and survivability of the lung cancer patient by Bayesian network
by: Chia-Ping Chen, et al.
Published: (2016)

Optimizing the sequence of targeted therapy in EGFR-mutant lung adenocarcinoma
by: Meador, Catherine Belle
Published: (2015)

Acquired Resistance to Targeted Therapy in EGFR-Mutant Lung Adenocarcinoma
by: Nebhan, Caroline Amalia
Published: (2014)

Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
by: Dana S. Neel, et al.
Published: (2017-03-01)

Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients
by: Zihuan Zhao, et al.
Published: (2020-05-01)

An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
by: Minghui Zhang, et al.
Published: (2019-12-01)

The Impact of Food-Away-From-Home Expenditure on Health Care Expenditure in Taiwan
by: 鄭雅君
Published: (2018)

The role of autophagy on targeted therapy in lung adenocarcinoma : in vitro and in vivo models
by: Li, Yuanyuan, et al.
Published: (2015)

Nutritional Status of Patients with Lung Adenocarcinoma Associated with Systemic Chemotherapy Care of Research
by: Yi-Hsin Liao, et al.
Published: (2016)

A Comparison of Health Care Expenditure of Cancer Terminal Stage Care Between Hospice and Nonhospice Patients
by: Nan-Ying Hu, et al.
Published: (2009)

The Analyses of Medical Expenditures and Three-year Survival Rate for Last-stage Lung Cancer Patients Using Targeted Medication in Taiwan
by: Ching-Han Chou, et al.
Published: (2018)

A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma
by: Xuelong Wang, et al.
Published: (2021-07-01)

Predicting Survivability and Medical Expenditure of Lung Cancer Patients Using Dynamic Bayesian Network
by: Muniroh, et al.
Published: (2019)

Clinical experience of effective use of palliative targeted therapy in a patient with EGFR-negative lung adenocarcinoma
by: L. M. Kogonia, et al.
Published: (2019-06-01)

TIFA Promotes Cell Survival and Migration in Lung Adenocarcinoma
by: Wanfu Men, et al.
Published: (2018-07-01)

Tumour Nuclear Morphometrics Predict Survival in Lung Adenocarcinoma
by: Najah M. Alsubaie, et al.
Published: (2021-01-01)

Effects of Diet Habit on Driver Genes and Survival in Chinese Patients with Lung Adenocarcinoma
by: Lai, Chun-Liang, et al.
Published: (2018)

Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients’ survival
by: Woon Yong Jung, et al.
Published: (2021-01-01)

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
by: Begoña Campos‐Balea, et al.
Published: (2020-11-01)

Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
by: Jin Duan, et al.
Published: (2021-04-01)

The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
by: Cheng WC, et al.
Published: (2021-01-01)

Predicting Medical Expenditure and Survivability of the Comorbidities Patients before Diagnosed with Lung Cancer by Bayesian Network
by: Ting-Yang Su, et al.
Published: (2017)

Incentives of Health Care Expenditure
by: Eero Siljander
Published: (2012-12-01)

The Impact of Medicare on the Distribution of Public Health Care Expenditures in Oklahoma
by: Coffey, Vernon Eugene
Published: (1972)

A diagnosis model for survivability and medical expenditure of lung cancer patient by Conditional Gaussian Bayesian networks
by: Wan-Ping Chen, et al.
Published: (2018)

Intratumoral immunoglobulin isotypes predict survival in lung adenocarcinoma subtypes
by: O. I. Isaeva, et al.
Published: (2019-10-01)

An expression signature model to predict lung adenocarcinoma-specific survival
by: Shi X, et al.
Published: (2018-09-01)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma
by: Zhou J, et al.
Published: (2018-10-01)

Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation
by: Bulent Erdogan, et al.
Published: (2016-11-01)

Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma.
by: Kikuchi, Ryutaro
Published: (2013)

Low-Level Expression of MTUS1 Is Associated with Poor Survival in Patients with Lung Adenocarcinoma
by: Seungyun Jee, et al.
Published: (2021-07-01)

Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
by: Xiaodong Yang, et al.
Published: (2019-07-01)

A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
by: Lei Liu, et al.
Published: (2021-09-01)

Smoking status affecting survival of adenocarcinoma lung cancer patients in Kuala Lumpur, Malaysia
by: Bangash, N.S.A, et al.
Published: (2017)

Survival, health care resource utilization and expenditures of first-line treatments for multiple myeloma patients ineligible for transplant in Taiwan.
by: Chih-Ning Cheng, et al.
Published: (2021-01-01)

Response to targeted therapy in urachal adenocarcinoma
by: Isabella Testa, et al.
Published: (2014-12-01)

Impact of Health Insurance on Health Care Utilisation and Out-of-Pocket Health Expenditure in Vietnam
by: Nguyen Thi Thu Thuong, et al.
Published: (2020-01-01)

Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options
by: Long Huang, et al.
Published: (2020-09-01)